Stay updated with breaking news from Vaccine Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The pandemic has been a game-changer for the pharmaceutical industry, sending globalisation into reverse. Here, Karen Winterhalter shares her expert insights.
The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).
Open Orphan report record revenues and EBITDA-profitability and significant operational progress
The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR). This new stage of the study – which wil
The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR). This new stage of the study – which wil